Voya Investment Management LLC increased its position in shares of Humana Inc. (NYSE:HUM) by 0.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 138,004 shares of the insurance provider’s stock after buying an additional 475 shares during the period. Voya Investment Management LLC owned 0.10% of Humana worth $33,206,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Guardian Life Insurance Co. of America boosted its holdings in Humana by 0.7% during the first quarter. Guardian Life Insurance Co. of America now owns 575 shares of the insurance provider’s stock worth $119,000 after buying an additional 4 shares in the last quarter. Acrospire Investment Management LLC purchased a new stake in Humana during the second quarter worth $120,000. Independent Portfolio Consultants Inc. boosted its holdings in Humana by 22.1% during the second quarter. Independent Portfolio Consultants Inc. now owns 519 shares of the insurance provider’s stock worth $125,000 after buying an additional 94 shares in the last quarter. Point72 Asia Hong Kong Ltd purchased a new stake in Humana during the first quarter worth $128,000. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in Humana by 139.5% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after buying an additional 325 shares in the last quarter. 95.12% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Humana Inc. (NYSE HUM) opened at 243.63 on Friday. The company’s 50-day moving average is $250.95 and its 200 day moving average is $232.23. The firm has a market capitalization of $35.21 billion, a PE ratio of 20.04 and a beta of 0.87. Humana Inc. has a 52-week low of $163.50 and a 52-week high of $259.76.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The business had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same period in the previous year, the firm earned $2.30 EPS. Equities analysts expect that Humana Inc. will post $11.55 earnings per share for the current fiscal year.

The company also recently announced a dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 29th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Thursday, September 28th. Humana’s payout ratio is 13.06%.

HUM has been the topic of a number of recent analyst reports. Citigroup Inc. initiated coverage on shares of Humana in a report on Wednesday, June 28th. They set a “buy” rating and a $275.00 price target on the stock. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a report on Friday, September 1st. BidaskClub downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Argus raised shares of Humana from a “hold” rating to a “buy” rating and set a $260.00 price target on the stock in a report on Friday, June 9th. Finally, Bank of America Corporation increased their price target on shares of Humana from $270.00 to $275.00 and gave the stock a “buy” rating in a report on Friday, July 14th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $246.60.

ILLEGAL ACTIVITY NOTICE: This report was first posted by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.watchlistnews.com/humana-inc-hum-position-increased-by-voya-investment-management-llc/1598697.html.

In related news, CEO Bruce D. Broussard sold 12,000 shares of the business’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $251.88, for a total value of $3,022,560.00. Following the completion of the transaction, the chief executive officer now owns 80,086 shares of the company’s stock, valued at approximately $20,172,061.68. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider William Kevin Fleming sold 3,071 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $250.98, for a total transaction of $770,759.58. Following the completion of the transaction, the insider now directly owns 7,681 shares of the company’s stock, valued at approximately $1,927,777.38. The disclosure for this sale can be found here. Insiders sold a total of 55,595 shares of company stock valued at $14,133,706 in the last three months. 0.80% of the stock is currently owned by corporate insiders.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.